In conclusion, elevated PRKD1 expression serves as a positive prognostic indicator in KIRC patients, while reduced PRKD1 expression is associated with a favorable prognosis in patients with THCA, STAD, and LIHC. Here, PRKD1 is linked to gastric adenocarcinoma.